ArticleMolecular metabolism2026
Corrigendum to "Metabolic plasticity and optimal redox homeostasis are essential for efficient metastatic colonization" [Mol Metab 109 (2026) 102382/42155637].
Abstract readPublished Erratum
In one paragraph
Article in Molecular metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
24 authors.
Ece GraceDepartment of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany.
Deyu ZouDepartment of Hematology, Oncology and Cell Therapy, Otto-von-Guericke-University of Magdeburg, Magdeburg, Germany.
Romy Böttcher-LoschinskiDepartment of Hematology, Oncology and Cell Therapy, Otto-von-Guericke-University of Magdeburg, Magdeburg, Germany; Magdeburg Centre for Cell and Immune Therapy (MAZI), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.
Martin BöttcherDepartment of Hematology, Oncology and Cell Therapy, Otto-von-Guericke-University of Magdeburg, Magdeburg, Germany; Magdeburg Centre for Cell and Immune Therapy (MAZI), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Healthcampus Immunology, Inflammation and Infectiology (GC-I3), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.
Harald SchuhwerkDepartment of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
Yussuf HajjajDepartment of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany.
Annemarie SchwabDepartment of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany.
Simon BrandtDepartment of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany.
Ana Clavel EzquerraDepartment of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany.
Witold SzymanskiInstitute of Translational Proteomics & Core Facility Translational Proteomics, Philipps-Universität Marburg, Marburg, Germany.
Johannes GraumannInstitute of Translational Proteomics & Core Facility Translational Proteomics, Philipps-Universität Marburg, Marburg, Germany.
Philipp ArnoldInstitute of Functional and Clinical Anatomy, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany.
Renato LiguoriDepartment of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany; Department of Nephropathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany.
Fulvia FerrazziDepartment of Nephropathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
Constantin P KrempeDepartment of Dermatology, University Hospital Essen, German Cancer Consortium (DKTK) and Research Alliance Ruhr, Research Center One Health, Campus Essen, Essen, Germany; Applied Analytical Chemistry, University of Duisburg-Essen, Essen, Germany.
Luiza Martins Nascentes MeloDepartment of Dermatology, University Hospital Essen, German Cancer Consortium (DKTK) and Research Alliance Ruhr, Research Center One Health, Campus Essen, Essen, Germany.
Gabriele AlliesDepartment of Dermatology, University Hospital Essen, German Cancer Consortium (DKTK) and Research Alliance Ruhr, Research Center One Health, Campus Essen, Essen, Germany.
Sven W MeckelmannApplied Analytical Chemistry, University of Duisburg-Essen, Essen, Germany.
Dirk MielenzDepartment of Translational Immunology, Department of Internal Medicine 3, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany.
Simone BrabletzDepartment of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
Dimitrios MougiakakosDepartment of Hematology, Oncology and Cell Therapy, Otto-von-Guericke-University of Magdeburg, Magdeburg, Germany; Magdeburg Centre for Cell and Immune Therapy (MAZI), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Healthcampus Immunology, Inflammation and Infectiology (GC-I3), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Health and Medical Prevention - CHAMP, Otto-von-Guericke University, Magdeburg, Germany.
Alpaslan TasdoganDepartment of Dermatology, University Hospital Essen, German Cancer Consortium (DKTK) and Research Alliance Ruhr, Research Center One Health, Campus Essen, Essen, Germany.
Thomas BrabletzDepartment of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
Marc P StemmlerDepartment of Experimental Medicine 1, Nikolaus-Fiebiger Center for Molecular Medicine, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Erlangen, Germany. Electronic address: marc.stemmler@fau.de.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.